Study the Safety and Efficacy of Probiotics Use in Premature Infants

University of Manitoba

Status: Withdrawn

Conditions: Infant, Premature, Diseases

Treatments: Dietary Supplement: breast milk; Dietary Supplement: breast milk with Bifidobacterium Longum subp. Infantis R0033

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01891604

jamesfriel2013

Details and patient eligibility

About

Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.

Sex: All

Ages: Under 2 days old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• born with weight<1500 g
• hospitalized within 48 hours after birth

Exclusion criteria

• present with evidence or suspicion of congenital intestinal obstruction
• perforation
• gastroschisis
• large omphalocele
• congenital diaphragmatic hernia
• major congenital heart defects